Figure S2. Target profiling of ingenol analog IngDsx (10). (A) Structure of ingenol disoxate
IngDsx, and corresponding biological activity. (B) Competition plot showing proteins for which enrichment by the Ing-DAyne probe (10 µM) was substantially blocked (> three-fold, red dotted line) by IngDsx (100 µM) in HSC5 cells. Named proteins are representative targets that were also competitively blocked by IngMb treatment (see Figure 3C ). Data represent the average from two biological replicates. See Table S1 for complete target lists. Figure 1 and Supplemental Information, reproduced three independent times in triplicate. Representative data shown as average values ± SD; n = 3 per group. (C) Expression of SLC25A20 (SLC) in HeLa cells reduces the IngMeb-mediated buildup long-chain acylcarnitines. Data represent average values ± SD; n = 3 per group; *p < 0.05, ***p < 0.001 and ****p < 0.0001 for SLC25A20-overexpressing versus mock groups.
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Cell Lines
HEK293T (ATCC) and HeLa (ATCC) cells were maintained in high-glucose DMEM (Gibco) supplemented with 10% (v/v) fetal bovine serum (FBS), penicillin (100 U/mL), streptomycin (100 μg/mL) and L-glutamine (2 mM). HSC-5 (human squamous cell carcinoma, Health Science Research Resource Bank, Japan) cells were maintained in high-glucose IMDM (Gibco) supplemented with 10% (v/v) fetal bovine serum (FBS), penicillin (100 U/mL) and streptomycin (100 μg/mL). HeKa (primary human keratinocytes, adult, Invitrogen) were grown in serum-free EpiLife medium with HKGS supplement containing 60 µM calcium following supplier's instructions, and were used between passages 2-10. All cell lines were grown at 37 ºC in a humidified 5% CO 2 atmosphere. For SILAC experiments, each cell line was passaged at least six times in either SILAC DMEM or SILAC IMDM, (Thermo), which lack L-lysine and L-arginine, and supplemented with 10% (v/v) dialyzed FBS (Gemini), PSQ (as above), and either 
Neutrophil oxidative burst assay
Primary human PMN (polymorphonuclear leukocytes) were isolated and purified from fresh buffy coats by sequential sedimentation, density centrifugation and lysis of contaminating erythrocytes. Buffy coats were incubated with 2% methocel for 30-45 min to differentially sediment red blood cells. The leukocyte-rich supernatant was transferred to Lymphoprep TM tubes to remove mononuclear cells by density centrifugation (400xg, 30 min). The pellet was re-suspended and any remaining erythrocytes lysed using 0.2% NaCl for 30 sec before restoring isotonicity by the addition of 1.2% NaCl. This step was repeated until the cell pellet appeared relatively free of red blood cells. 
Human PKC delta (PKCδ) activation assay
The potency and efficacy of test compounds in stimulating human recombinant protein kinase C (PKC) delta isoform was determined by measuring phosphorylation of a PKC substrate peptide using 33 P-ATP. Data points for the EC50 determinations were performed in duplicate. The assay was performed at Millipore (Dundee, UK).
Human PKC delta (PKCδ, Millipore cat# 14-504) was diluted in 20 mM HEPES, 0.03% Triton X-100. Amount of enzyme in each assay was 7.25 ng, final assay volume 25 µl. All compounds for testing were diluted to 1 mM in 100% DMSO as an intermediary dilution. The compounds were then diluted further to 50 μM, and then serially diluted in 100% DMSO in semi-logarithmic decrements for 12 points.
0.5 μL of each concentration, in duplicate, was pipetted into a dry 96 well assay plate using a TTP Mosquito. Control and blank wells received 0.5 μL of 100% DMSO instead of compound. This was followed by addition of 14.5 μL of assay mixture, containing appropriately diluted enzyme and 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.05 mg/mL phosphatidylserine, and 50 μM of the substrate peptide ERMRPRKRQGSVRRRV. The assay was started with the addition of 10 μL ATP containing γ-33P-ATP (specific activity approx. 500 cpm/pmol) to a final assay concentration of 15 μM. The reaction was allowed to proceed at room temperature for 40 minutes before the addition of 5 μL 3% ortho-phosphoric acid.
Blank wells were acid blanks, and had 5 μL 3% ortho-phosphoric acid added before the addition of ATP. 10 μL of the stopped reaction products was transferred to a P30 filtermat which was then washed 4 times in 75 mM ortho-S11 phosphoric acid, and once in methanol before drying. The filter was read by liquid scintillation counting using a Wallac Trilux. 
Acute cancer cell cytotoxicity assay
Preparation of probe-labeled proteome for gel-and MS-based protein analyses
Cells pellets were lysed in cold DPBS (100-500 µL) using a Branson Sonifier probe sonicator (10 pulses, 30% duty cycle, output setting = 4). For experiments requiring cell fractionation into membrane and soluble proteomes, cell lysates were then centrifuged (100,000 x g, 45 min) to provide soluble (supernatant) and membrane (pellet) fractions. Membrane pellets were resuspended in cold DPBS after separation by sonication. Protein concentration was determined using the DC Protein Assay (Bio-Rad) and absorbance read using a Tecan, Infinite F500 plate reader following manufacturer's instructions. For SILAC and ReDiMe experiments, whole cell lysates were adjusted to 1.5 mg/mL, and for SILAC experiments were then mixed in equal proportions (500 µL each) in cold DPBS.
For ReDiMe experiments, lysates were kept separate.
Gel-based analysis of crosslinked proteins in cells
Proteomes from treated cells were diluted to 1 mg/mL. To each sample (50 µL), 6
µL of a freshly prepared "click" reagent mixture containing 0. 
Preparation of labeled proteome for MS-based analysis -SILAC
Profiling experiments were adapted methods previously reported. 
Preparation of labeled proteome from primary keratinocytes for MS-based analysis -Reductive dimethylation (ReDiMe)
Profiling experiments were adapted methods previously reported. 2, 3 HeKa cells and lysates were prepared as described above and samples to be isotopically labeled with either 'light' or 'heavy' formaldehyde were kept separate at 500 µL 
Multidimensional liquid chromatography-tandem mass spectrometry (LC/LC-MS/MS) analysis of tryptic digests
Peptides from tryptic digests were pressure loaded onto a 250 μm (inner diameter) fused silica capillary column packed with C18 resin (4 cm, Aqua 5 μm, S16 Phenomenex). Samples were analyzed using an LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific) coupled to an Agilent 1200 series quaternary pump. Peptides were eluted by two-dimensional separation on a column with a 5 μm tip [100 μm fused silica, packed with C18 (10 cm) and strong cation exchange (SCX) resin (4 cm, Phenomenex)] using a five-step 'MudPIT' protocol 4 that involves 0%, 25%, 50%, 80% and 100% salt bumps of ammonium acetate (NH 4 OAc; 500 mM) to elute peptides stepwise from the SCX to the C18 resin followed by an increasing gradient of acetonitrile in each step (5%-100% buffer B in buffer A; buffer A: 95% H 2 O, 5% acetonitrile, 0.1% formic acid; buffer B: 5% 
Peptide and protein identification and quantification
From each of the five .raw files (one for each salt 'bump') generated by the instrument (Xcalibur software), the MS2 spectra for all fragmented parent ions (.ms2 file) were extracted using RAW Xtract (version 1.9.9.2; 2004 release).
Each .ms2 file was searched using the ProLuCID algorithm against a reverseconcatenated, nonredundant (gene-centric) database of the human proteome (Uniprot release -11/05/2012) or mouse proteome (11/05/2012) and filtered using DTASelect 2.0 within the Integrated Proteomics Pipeline (IP2) software. All cysteine residues were specified with a static modification for carbamidomethylation (+57.0215 Da) and one oxidized methionine residue per peptide (if found) was allowed as a variable oxidation (+15.9949 Da). In addition, S17 peptides were required to have at least one tryptic terminus. For ReDiMe samples, each dataset was simultaneously searched for both light and heavy isotopologues of the same peptide by specifying the mass shift of light and heavy residues as static modifications; for the 'light' search, static modifications on lysine and N-termini (+28.0313 m/z) were specified; for the 'heavy' search, static modifications on lysine (+34.06312 m/z) and N-termini were specified (+34.06312 m/z). For SILAC samples, each dataset was simultaneously searched for both light and heavy isotopologues of the same peptide by specifying the mass shift of heavy residues as static modifications on lysine (+8.0142 Da) and arginine (+10.0082 Da) in a coupled 'heavy' search. The precursor ion mass tolerance for a minimum envelope of three isotopic peaks was set to 50 ppm, the minimum peptide length was six residues, the false-positive rate was set at 1% or lower and at least 2 peptides of a protein must be detected in order to be advanced to the next step of analysis.
Heavy and light parent ion chromatograms associated with successfully identified peptides were extracted and compared using in-house software (CIMAGE) as previously described 5 . Briefly, extracted MS1 ion chromatograms (± 10 ppm error tolerance of predicted m/z) from both 'light' and 'heavy' target peptide masses (m/z) were generated using a retention time window (± 10 min) centered on the time when the peptide ion was selected for MS/MS fragmentation (minimum 3 MS1's per peak), and subsequently identified. Next, the ratio of the peak areas under the light and heavy signals (signal-to-noise ratio > 2.5) was calculated. Computational filters used to ensure that the correct peak-pair was used for quantification include a co-elution correlation score filter (R 2 ≥ 0.8),
removing target peptides with bad co-elution profile, and an 'envelope correlation score' filter (R 2 > 0.8) that eliminates target peptides whose predicted pattern of the isotopic envelope distribution does not match the experimentally observed high-resolution MS1 spectrum. In addition, peptides detected as 'singletons,'
where only the heavy ion of a peptide pair was identified, but that cleared all other filtering parameters, are given a default assigned ratio of '20,' which is S18 defined as any measured ratio that is ≥ 20 and is the maximum ratio reported here. Unprocessed raw data for multiple examples of each experimental type provided in Table S1 .
Proteomic analysis of probe-labeled proteins by mass spectrometry
Median SILAC/ReDiMe ratios were filtered to ensure that each protein ratio was resultant from three or more unique and quantified peptides and that the combined peptide ratios possessed a standard deviation of less than 10.
SILAC/ReDiMe ratios meeting these criteria were then averaged across replicate datasets from the same cells and treatment conditions; if the median ratios were greater than 60% of the mean, the ratio was assigned the lowest median ratio. All MS-based experiments were performed in two more biological replicates. Serumderived/contaminant Keratin, Albumin, Trypsin, Hornerin and Statherin proteins manually removed from protein lists.
In order to be classified as a probe target, proteins must (1) comply with the above criteria and (2) be enriched greater than 5-fold in UV versus no-UV experiments. Targets fulfilling these criteria are shown in Table S1 along with representative raw data sets. For competition experiments, in order to be designated a target of the competitor (e.g. ingenol mebutate), proteins (1) must be designated probe targets, as described above and (2) competed greater than 3-fold (competition SILAC/ReDiMe ratio >3) unless otherwise noted. Targets fulfilling these criteria are shown in Table S1 along with representative raw data sets.
Cloning and transient overexpression of proteins in HEK293T cells
Unless otherwise noted, cDNAs were cloned from hORFeome library using For cytotoxicity experiments with HeLa transfected cells, cell transfected as described above, for 24 hours. Cell then harvested and seeded into 96-well plates overnight and treated as described above.
Western blot analysis
After scanning for fluorescence, proteins were transferred to a nitrocellulose membrane in Towbin buffer, the membrane was blocked for ~1 hr at ambient temperature with 5% nonfat dry milk (w/v) or 5% BSA in Tris-buffered saline with 
LCMS analysis of acylcarnitines in HSC-5 cells
Profiling experiments were adapted methods previously reported. 1 
Oxygen Consumption Rate Measurements
Palmitate-BSA oxidation measurements were performed using a Seahorse 
Quantification and Statistical Analysis
All data fitting and statistical analysis performed using GraphPad Prism version 
Chemistry Materials
Purchased starting materials were used as received unless otherwise noted. All showed that all starting material was consumed. The reaction mixture was poured into a separation funnel with MTBE (500 ml) and saturated aq. NaHCO 3 (500 ml). The layers were separated and the organic layer was washed with a 1:1 mixture of water and saturated aq. NaHCO 3 (500 ml) and then with brine (500 ml). The organic layer was dried over sodium sulfate, filtered, and concentrated in vacuo. The crude mixture was used in the next step without further purification.
3-(S)-azido-3-deoxy-ingenol
Crude mesylate (12.0 g, 25.7 mmol) was dissolved in DMF (100 ml). Sodium azide (7.00 g, 108 mmol) was added and the suspension was stirred at 60°C for 45 min. The reaction mixture was cooled on an ice bath and water (~100 ml) was added slowly. The structure of 6 was confirmed on the basis of X-ray crystallographic analysis.
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